International journal of surgery case reports · 2026
Primary breast diffuse large B-cell lymphoma mimicking breast carcinoma: a diagnostic challenge - case report.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Khadour Yazan Soliman, Mreabi Khoder, Elmohazzem Abdelhaleem, Zoghby Rana, Salman Hussam, Hammoud Bashar
Аннотация
INTRODUCTION: Primary breast lymphoma (PBL) is a rare malignancy that may clinically and radiologically mimic breast carcinoma. Accurate pathological diagnosis is essential to guide treatment and avoid unnecessary radical surgery.
PRESENTATION OF CASE: A 47-year-old woman presented with a painless right breast mass and ipsilateral axillary lymphadenopathy. Initial core-needle histology was interpreted as grade 2 invasive ductal carcinoma, and the patient underwent right mastectomy with axillary dissection. Postoperative immunohistochemistry (IHC) showed tumor cells positive for CD20 and negative for cytokeratin and T-cell markers, consistent with primary breast diffuse large B-cell lymphoma (PB-DLBCL). The patient received six cycles of R-CHOP and remains in complete remission at a 2-year follow-up.
DISCUSSION: PBL may be morphologically indistinguishable from carcinoma on limited H&E sections. Therefore, IHC is essential to differentiate lymphoma from epithelial malignancy; when feasible, adequate preoperative sampling and targeted immunostains should be considered to prevent unnecessary mastectomy. R-CHOP chemotherapy is the mainstay of treatment for PB-DLBCL.
CONCLUSION: Consider PBL in the differential diagnosis of breast masses. Adequate sampling and IHC are crucial to directing appropriate, non-surgical therapy.
PRESENTATION OF CASE: A 47-year-old woman presented with a painless right breast mass and ipsilateral axillary lymphadenopathy. Initial core-needle histology was interpreted as grade 2 invasive ductal carcinoma, and the patient underwent right mastectomy with axillary dissection. Postoperative immunohistochemistry (IHC) showed tumor cells positive for CD20 and negative for cytokeratin and T-cell markers, consistent with primary breast diffuse large B-cell lymphoma (PB-DLBCL). The patient received six cycles of R-CHOP and remains in complete remission at a 2-year follow-up.
DISCUSSION: PBL may be morphologically indistinguishable from carcinoma on limited H&E sections. Therefore, IHC is essential to differentiate lymphoma from epithelial malignancy; when feasible, adequate preoperative sampling and targeted immunostains should be considered to prevent unnecessary mastectomy. R-CHOP chemotherapy is the mainstay of treatment for PB-DLBCL.
CONCLUSION: Consider PBL in the differential diagnosis of breast masses. Adequate sampling and IHC are crucial to directing appropriate, non-surgical therapy.